CRESCENT BIOPHARMA, INC. Operating Income
CRESCENT BIOPHARMA, INC. (CBIO) reported Operating Income of -$26.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- CRESCENT BIOPHARMA, INC. operating income (loss) for the quarter ending 2026-06-30 was -$26.36M.
- CRESCENT BIOPHARMA, INC. operating income (loss) for the quarter ending 2026-03-31 was -$24.73M.
- CRESCENT BIOPHARMA, INC. operating income (loss) for the quarter ending 2025-12-31 was -$91.49M.
- CRESCENT BIOPHARMA, INC. operating income (loss) for the quarter ending 2025-09-30 was -$25.89M.
- CRESCENT BIOPHARMA, INC. operating income (loss) for fiscal 2025 was -$152.63M.
- CRESCENT BIOPHARMA, INC. operating income (loss) for fiscal 2024 was -$40.04M.
- CRESCENT BIOPHARMA, INC. operating income (loss) for fiscal 2023 was -$39.28M.
- CRESCENT BIOPHARMA, INC. operating income (loss) for fiscal 2022 was -$47.40M.
| Period end | Operating Income (Loss) 0 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 130 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$26.36M 10-Q · filed 2026-07-30 | -$51.09M 10-Q · filed 2026-07-30 | -$142.59M derived: sum of 3 quarters · filed 2026-07-30 | -$168.47M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | -$24.73M 10-Q · filed 2026-04-29 | -$116.22M derived: sum of 2 quarters · filed 2026-04-29 | -$142.11M derived: sum of 3 quarters · filed 2026-04-29 | -$163.14M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | -$91.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$117.38M derived: sum of 2 quarters · filed 2026-02-26 | -$138.41M derived: sum of 3 quarters · filed 2026-07-30 | -$152.63M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$25.89M 10-Q · filed 2025-11-06 | -$46.91M derived: sum of 2 quarters · filed 2026-07-30 | -$61.14M 10-Q · filed 2025-11-06 | -$78.33M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$21.03M 10-Q · filed 2026-07-30 | -$35.26M 10-Q · filed 2026-07-30 | -$52.45M derived: sum of 3 quarters · filed 2026-07-30 | -$63.68M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | -$14.22M 10-Q · filed 2026-04-29 | -$2.40M 10-Q · filed 2025-05-14 | -$31.41M derived: sum of 2 quarters · filed 2026-04-29 | -$42.65M derived: sum of 3 quarters · filed 2026-04-29 | -$53.01M derived: sum of 4 quarters · filed 2026-04-29 | ||
| 2024-12-31 | -$17.19M 10-K · filed 2026-02-26 | -$28.42M derived: sum of 2 quarters · filed 2026-02-26 | -$38.78M derived: sum of 3 quarters · filed 2026-02-26 | -$40.04M 10-K · filed 2025-02-13 | |||
| 2024-09-30 | -$2.63M 10-Q · filed 2025-11-06 | -$11.23M 10-Q · filed 2024-11-13 | -$21.59M derived: sum of 2 quarters · filed 2024-11-13 | -$32.71M 10-Q · filed 2024-11-13 | -$42.30M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-06-30 | -$10.36M 10-Q · filed 2024-08-08 | -$21.47M 10-Q · filed 2024-08-08 | -$31.06M derived: sum of 3 quarters · filed 2025-05-14 | -$40.88M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2024-03-31 | -$11.12M 10-Q · filed 2025-05-14 | -$20.71M derived: sum of 2 quarters · filed 2025-05-14 | -$30.52M derived: sum of 3 quarters · filed 2025-05-14 | -$39.45M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$9.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$19.40M derived: sum of 2 quarters · filed 2025-02-13 | -$28.33M derived: sum of 3 quarters · filed 2025-02-13 | -$39.28M 10-K · filed 2025-02-13 | |||
| 2023-09-30 | -$9.81M 10-Q · filed 2024-11-13 | -$18.74M derived: sum of 2 quarters · filed 2024-11-13 | -$29.68M 10-Q · filed 2024-11-13 | -$40.31M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -$8.93M 10-Q · filed 2024-08-08 | -$19.87M 10-Q · filed 2024-08-08 | -$30.49M derived: sum of 3 quarters · filed 2024-08-08 | -$39.26M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$10.94M 10-Q · filed 2024-05-09 | -$21.56M derived: sum of 2 quarters · filed 2024-05-09 | -$30.33M derived: sum of 3 quarters · filed 2024-05-09 | -$43.68M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$19.39M derived: sum of 2 quarters · filed 2024-03-27 | -$32.74M derived: sum of 3 quarters · filed 2024-03-27 | -$47.40M 10-K · filed 2024-03-27 | |||
| 2022-09-30 | -$8.77M 10-Q · filed 2023-11-03 | -$22.12M derived: sum of 2 quarters · filed 2023-11-03 | -$36.78M 10-Q · filed 2023-11-03 | -$54.21M derived: sum of 4 quarters · filed 2024-03-27 | |||
| 2022-06-30 | -$13.35M 10-Q · filed 2023-08-02 | -$28.01M 10-Q · filed 2023-08-02 | -$45.44M derived: sum of 3 quarters · filed 2024-03-27 | -$62.78M derived: sum of 4 quarters · filed 2024-03-27 | |||
| 2022-03-31 | -$14.66M 10-Q · filed 2023-05-03 | -$32.09M derived: sum of 2 quarters · filed 2024-03-27 | -$49.42M derived: sum of 3 quarters · filed 2024-03-27 | -$63.83M derived: sum of 4 quarters · filed 2024-03-27 | |||
| 2021-12-31 | -$17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$34.76M derived: sum of 2 quarters · filed 2024-03-27 | -$49.17M derived: sum of 3 quarters · filed 2024-03-27 | -$63.45M 10-K · filed 2024-03-27 | |||
| 2021-09-30 | -$17.34M 10-Q · filed 2022-11-09 | -$31.74M derived: sum of 2 quarters · filed 2022-11-09 | -$46.02M 10-Q · filed 2022-11-09 | -$61.59M derived: sum of 4 quarters · filed 2023-03-29 | |||
| 2021-06-30 | -$14.40M 10-Q · filed 2022-08-03 | -$28.68M 10-Q · filed 2022-08-03 | -$44.25M derived: sum of 3 quarters · filed 2023-03-29 | -$57.98M derived: sum of 4 quarters · filed 2023-03-29 | |||
| 2021-03-31 | -$14.28M 10-Q · filed 2022-04-28 | -$29.85M derived: sum of 2 quarters · filed 2023-03-29 | -$43.58M derived: sum of 3 quarters · filed 2023-03-29 | -$57.68M derived: sum of 4 quarters · filed 2023-03-29 | |||
| 2020-12-31 | -$15.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$29.30M derived: sum of 2 quarters · filed 2023-03-29 | -$43.40M derived: sum of 3 quarters · filed 2023-03-29 | -$51.51M 10-K · filed 2023-03-29 | |||
| 2020-09-30 | -$13.73M 10-Q · filed 2021-11-02 | -$27.83M derived: sum of 2 quarters · filed 2021-11-02 | -$35.94M 10-Q · filed 2021-11-02 | -$51.28M derived: sum of 4 quarters · filed 2022-03-03 | |||
| 2020-06-30 | -$14.11M 10-Q · filed 2021-08-05 | -$22.21M 10-Q · filed 2021-08-05 | -$37.55M derived: sum of 3 quarters · filed 2022-03-03 | -$51.65M derived: sum of 4 quarters · filed 2022-03-03 | |||
| 2020-03-31 | -$8.11M 10-Q · filed 2021-05-03 | -$23.44M derived: sum of 2 quarters · filed 2022-03-03 | -$37.55M derived: sum of 3 quarters · filed 2022-03-03 | -$54.36M derived: sum of 4 quarters · filed 2022-03-03 | |||
| 2019-12-31 | -$15.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$29.44M derived: sum of 2 quarters · filed 2022-03-03 | -$46.26M derived: sum of 3 quarters · filed 2022-03-03 | -$61.39M 10-K · filed 2022-03-03 | |||
| 2019-09-30 | -$14.11M 10-Q · filed 2020-11-06 | -$30.92M derived: sum of 2 quarters · filed 2020-11-06 | -$46.05M 10-Q · filed 2020-11-06 | -$61.01M derived: sum of 4 quarters · filed 2021-03-02 | |||
| 2019-06-30 | -$16.82M 10-Q · filed 2020-07-31 | -$31.95M 10-Q · filed 2020-07-31 | -$46.91M derived: sum of 3 quarters · filed 2021-03-02 | -$59.43M derived: sum of 4 quarters · filed 2021-03-02 | |||
| 2019-03-31 | -$15.13M 10-Q · filed 2020-05-01 | -$30.09M derived: sum of 2 quarters · filed 2021-03-02 | -$42.61M derived: sum of 3 quarters · filed 2021-03-02 | -$54.76M derived: sum of 4 quarters · filed 2021-03-02 | |||
| 2018-12-31 | -$14.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$27.48M derived: sum of 2 quarters · filed 2021-03-02 | -$39.63M derived: sum of 3 quarters · filed 2021-03-02 | -$51.50M 10-K · filed 2021-03-02 | |||
| 2018-09-30 | -$12.52M 10-Q · filed 2019-11-07 | -$24.67M derived: sum of 2 quarters · filed 2019-11-07 | -$36.54M 10-Q · filed 2019-11-07 | -$46.35M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-06-30 | -$12.15M 10-Q · filed 2018-08-09 | -$24.03M 10-Q · filed 2019-08-01 | -$33.83M derived: sum of 3 quarters · filed 2020-02-28 | -$42.02M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | -$12.15M 10-Q · filed 2019-08-01 | -$11.88M 10-Q · filed 2018-05-03 | -$21.68M derived: sum of 2 quarters · filed 2020-02-28 | -$29.87M derived: sum of 3 quarters · filed 2020-02-28 | -$38.11M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | -$9.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$17.72M derived: sum of 2 quarters · filed 2020-02-28 | -$25.96M derived: sum of 3 quarters · filed 2020-02-28 | -$33.93M 10-K · filed 2020-02-28 | |||
| 2017-09-30 | -$8.18M 10-Q · filed 2018-11-02 | -$16.43M derived: sum of 2 quarters · filed 2018-11-02 | -$24.40M 10-Q · filed 2018-11-02 | -$32.75M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-06-30 | -$8.24M 10-Q · filed 2018-08-09 | -$16.21M 10-Q · filed 2018-08-09 | -$24.57M derived: sum of 3 quarters · filed 2019-03-06 | -$32.46M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-03-31 | -$7.97M 10-Q · filed 2018-05-03 | -$16.33M derived: sum of 2 quarters · filed 2019-03-06 | -$24.22M derived: sum of 3 quarters · filed 2019-03-06 | -$32.31M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2016-12-31 | -$8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$16.25M derived: sum of 2 quarters · filed 2019-03-06 | -$24.34M derived: sum of 3 quarters · filed 2019-03-06 | -$31.91M 10-K · filed 2019-03-06 | |||
| 2016-09-30 | -$7.89M 10-Q · filed 2017-11-08 | -$15.98M derived: sum of 2 quarters · filed 2017-11-08 | -$23.56M 10-Q · filed 2017-11-08 | -$32.44M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | -$8.09M 10-Q · filed 2017-08-03 | -$15.67M 10-Q · filed 2017-08-03 | -$24.56M derived: sum of 3 quarters · filed 2018-03-06 | -$31.73M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | -$7.58M 10-Q · filed 2017-05-08 | -$16.46M derived: sum of 2 quarters · filed 2018-03-06 | -$23.63M derived: sum of 3 quarters · filed 2018-03-06 | -$13.25M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | -$8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$16.06M derived: sum of 2 quarters · filed 2018-03-06 | -$5.67M derived: sum of 3 quarters · filed 2018-03-06 | -$12.78M 10-K · filed 2018-03-06 | |||
| 2015-09-30 | -$7.17M 10-Q · filed 2016-11-04 | $3.22M derived: sum of 2 quarters · filed 2016-11-04 | -$3.90M 10-Q · filed 2016-11-04 | -$11.30M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $10.39M 10-Q · filed 2016-08-04 | $3.27M 10-Q · filed 2016-08-04 | -$4.12M derived: sum of 3 quarters · filed 2017-03-01 | -$10.82M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | -$7.11M 10-Q · filed 2016-05-04 | -$14.51M derived: sum of 2 quarters · filed 2017-03-01 | -$21.21M derived: sum of 3 quarters · filed 2017-03-01 | -$13.15M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | -$7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$14.10M derived: sum of 2 quarters · filed 2017-03-01 | -$6.03M derived: sum of 3 quarters · filed 2017-03-01 | -$11.14M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | -$6.70M 10-Q · filed 2015-11-12 | $1.37M derived: sum of 2 quarters · filed 2015-11-12 | -$3.74M 10-Q · filed 2015-11-12 | -$7.61M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $8.06M 10-Q · filed 2015-08-06 | $2.96M 10-Q · filed 2015-08-06 | -$909.75K derived: sum of 3 quarters · filed 2016-02-29 | -$4.61M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$5.11M 10-Q · filed 2015-05-05 | -$8.97M derived: sum of 2 quarters · filed 2016-02-29 | -$12.67M derived: sum of 3 quarters · filed 2016-02-29 | -$16.17M derived: sum of 4 quarters · filed 2016-02-29 | -$68.30M 10-Q · filed 2014-05-09 | ||
| 2013-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$7.57M derived: sum of 2 quarters · filed 2016-02-29 | -$11.07M derived: sum of 3 quarters · filed 2016-02-29 | -$10.61M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$3.70M 10-Q · filed 2014-10-31 | -$7.20M derived: sum of 2 quarters · filed 2014-10-31 | -$6.74M 10-Q · filed 2014-10-31 | ||||
| 2013-06-30 | -$3.50M 10-Q · filed 2014-07-31 | -$3.04M 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $458.72K 10-Q · filed 2014-05-09 | ||||||
| 2012-12-31 | $3.64M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |